Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Deciphera Pharmaceuticals Q4 EPS $(0.54) Beats $(0.58) Estimate, Sales $48.30M Beat $45.92M Estimate

Author: Benzinga Newsdesk | February 06, 2024 08:01am
Deciphera Pharmaceuticals (NASDAQ:DCPH) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.58) by 6.9 percent. This is a 10 percent increase over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $48.30 million which beat the analyst consensus estimate of $45.92 million by 5.17 percent. This is a 32.88 percent increase over sales of $36.34 million the same period last year.

Posted In: DCPH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist